Coverage
-
September 30, 2021
A New Jersey federal judge Thursday nixed Allergan's bid to toss a generic drug price-fixing lawsuit on the grounds that funds affiliated with TIAA-CREF were too late in filing their claims since similar antitrust actions based on related government investigations were filed more than a year earlier.
3 other articles on this case.
View all »